Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.

Xin TuYuanyuan ZhaoQianqian LiXiao YuYang YangShumei ShiZuochuan DingYan MiaoZhimiao ZouXinqiang WangJipin JiangDunfeng Du

Published in: Clinical and experimental nephrology (2019)

MiR-4660 is probably a new biomarker for mutation-negative idiopathic oxalosis by regulating the post-transcription of AGXT, providing a potential treatment target of mutation-negative idiopathic oxalosis.

Keyphrases

long non coding rna
cell proliferation
poor prognosis
long noncoding rna
endothelial cells
transcription factor
induced pluripotent stem cells
binding protein